All Posts By

Smartkarma Daily Briefs

Daily Brief Event-Driven: First Pacific (142 HK) Is Fully Valued Here and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • First Pacific (142 HK) Is Fully Valued Here
  • True Aspect (Trade-Wise) Of the Samsung Life Accounting Issue: Today’s Biggest Market Narrative
  • Shibaura Electronics (6957 JP): Yageo Goes All in with a JPY6,635 Offer
  • PointsBet (PBH AU): Mixi Attempts to Call Betr’s Bluff with a Final Offer
  • PointsBet (PBH AU): Mixi Bumps, Again, And Declares Terms Final
  • MFE-ProSieben: Spread Closed, Control Still in Play


First Pacific (142 HK) Is Fully Valued Here

By David Blennerhassett


True Aspect (Trade-Wise) Of the Samsung Life Accounting Issue: Today’s Biggest Market Narrative

By Sanghyun Park

  • Both accounting issues are complex, but intense regulator scrutiny fuels the Samsung Life Act case, sparking governance reshuffle bets and driving today’s Samsung Life stock pop.
  • Accounting rechecks could spark divestment fears or governance-driven rerating, creating a classic headline-driven, bidirectional trading setup.
  • Near-Term, this is a headline-driven momentum setup: Samsung Life longs/shorts, ready to pivot, with relative-value plays vs financial peers or Samsung’s governance-linked names.

Shibaura Electronics (6957 JP): Yageo Goes All in with a JPY6,635 Offer

By Arun George

  • In response to Minebea Mitsumi (6479 JP) matching its Shibaura Electronics (6957 JP) offer on 14 August, Yageo Corporation (2327 TT) increased its offer by 7.0% from JPY6,200 to JPY6,635.  
  • To remain in the game, Yageo had to bump. The latest bump underscores Yageo’s confidence in securing regulatory approvals. 
  • The Minebea CEO suggested that its JPY6,200 offer would be the final one. If Yageo secures regulatory approval (likely), Minebea will walk rather than match Yageo’s latest offer. 

PointsBet (PBH AU): Mixi Attempts to Call Betr’s Bluff with a Final Offer

By Arun George

  • Mixi Inc (2121 JP) disclosed its final PointsBet Holdings (PBH AU) offer. The base unconditional offer remains A$1.25 but will be increased to A$1.30 if it acquires a 90% stake. 
  • Mixi’s final offer is designed to put maximum pressure on BETR Entertainment (BBT AU) to fold. Mixi would not satisfy the 90% threshold unless Betr accepts its offer.
  • Betr has three options: to improve its offer, accept Mixi’s offer, or maintain terms. The last option, which results in a significant stake in a competitor, makes strategic sense.

PointsBet (PBH AU): Mixi Bumps, Again, And Declares Terms Final

By David Blennerhassett

  • Mixi Inc (2121 JP) has bumped its Offer to A$1.30/share, up from A$1.25/share; and declared terms final. Mixi currently holds 37.12% of shares out. 
  • Separately, PointsBet Holdings (PBH AU) released its Target Statement as it relates betr Entertainment (BBT AU)‘s all-scrip Offer, with a definitive “Reject”.
  • Mixi’s Offer is open to the 29th August – and will not be extended. Time for betr to fold its tent.

MFE-ProSieben: Spread Closed, Control Still in Play

By Jesus Rodriguez Aguilar

  • MFE secured 43.6% of ProSieben; board supports its offer. PPF stalled at 18.4% with expired bid. The arbitrage spread compressed, leaving minimal upside but structural consolidation remains pivotal.
  • Short-Term arbitrage returns are capped (+0.4% base case), while downside risk persists if blocking dynamics resurface. The medium-term value case depends on synergy delivery, with 18–35% EPS accretion possible.
  • Key milestones: September 1 end of extended acceptance, September 4 final results. Thereafter, MFE may pursue creeping acquisitions under Germany’s best-price rule, progressively consolidating control and enabling strategic integration.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Ryohin Keikaku, PointsBet Holdings , Shanghai Forest Cabin Biological-Tech, Newton Golf Company, Dentsu Inc, ProSiebenSat.1 Media SE, TSE Tokyo Price Index TOPIX, Aramark, Vince Holding and more

By | Consumer, Daily Briefs

In today’s briefing:

  • [Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Ryohin Keikaku (7453 JP)
  • PointsBet (PBH AU): Mixi Attempts to Call Betr’s Bluff with a Final Offer
  • PointsBet (PBH AU): Mixi Bumps, Again, And Declares Terms Final
  • Shanghai Forest Cabin Biological Tech. Pre-IPO: A Play on Aging Population But With A Few Wrinkles
  • NWTG: Newton Golf reports strong 2nd quarter 2025 revenue growth. The Newton Shaft lineup continues to be the primary growth driver.
  • Dentsu Group — Japan performs well, international tougher
  • MFE-ProSieben: Spread Closed, Control Still in Play
  • Isn’t the Market Impatient for the Companies to Implement Management Reforms?
  • Aramark: Initiation Of Coverage- How They Are Thriving In Sports & Education & Why Their Revenues Keep Climbing?
  • VNCE: Snapping the Store: Creating New Seasons; Reiterate Buy, $4 PT


[Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Ryohin Keikaku (7453 JP)

By Travis Lundy

  • On 26 August at the close, 2 names will get added to and 5 names deleted from a global index provider’s major Japan/global “standard” index.
  • 6 of 7 changes were in the Quiddity Index predictions as of end Jun-2025. One dropped, then two got added. Our final predictions had all seven plus one more DEL.
  • They were well-flagged so well pre-positioned. This insight looks at shareholder structure, historical fundamental ratios, and performance vs Peers. This sets up a possible trade before or into the event.

PointsBet (PBH AU): Mixi Attempts to Call Betr’s Bluff with a Final Offer

By Arun George

  • Mixi Inc (2121 JP) disclosed its final PointsBet Holdings (PBH AU) offer. The base unconditional offer remains A$1.25 but will be increased to A$1.30 if it acquires a 90% stake. 
  • Mixi’s final offer is designed to put maximum pressure on BETR Entertainment (BBT AU) to fold. Mixi would not satisfy the 90% threshold unless Betr accepts its offer.
  • Betr has three options: to improve its offer, accept Mixi’s offer, or maintain terms. The last option, which results in a significant stake in a competitor, makes strategic sense.

PointsBet (PBH AU): Mixi Bumps, Again, And Declares Terms Final

By David Blennerhassett

  • Mixi Inc (2121 JP) has bumped its Offer to A$1.30/share, up from A$1.25/share; and declared terms final. Mixi currently holds 37.12% of shares out. 
  • Separately, PointsBet Holdings (PBH AU) released its Target Statement as it relates betr Entertainment (BBT AU)‘s all-scrip Offer, with a definitive “Reject”.
  • Mixi’s Offer is open to the 29th August – and will not be extended. Time for betr to fold its tent.

Shanghai Forest Cabin Biological Tech. Pre-IPO: A Play on Aging Population But With A Few Wrinkles

By Hong Jie Seow

  • Shanghai Forest Cabin Biological-Tech (SFCBT HK)  is looking to raise at least US$100m in its upcoming Hong Kong IPO.
  • SFC is the leader among China’s premium domestic skincare brands. In 2024, SFC was ranked first among all premium domestic skincare brands in China by retail sales.
  • In this note, we look at the company’s past performance.

NWTG: Newton Golf reports strong 2nd quarter 2025 revenue growth. The Newton Shaft lineup continues to be the primary growth driver.

By Zacks Small Cap Research

  • Newton Golf (NASDAQ: NWTG) is an innovative, technology driven golf company with a growing portfolio of golf products, including putters, golf shafts, golf grips, and other golf-related accessories.
  • The company went public in August 2023 raising $11.6 million in net proceeds.
  • The company announced its entry into the golf shaft market in November 2023.

Dentsu Group — Japan performs well, international tougher

By Edison Investment Research

Dentsu’s Q225 performance was a little below management expectations, with conditions remaining challenging outside Japan. Group operating margins were controlled for H125 at 12.0%. With a further goodwill write-down of ¥86.0bn, Dentsu reported a statutory loss for H125 and is not now paying an interim dividend. A decision on the full year will be made later, and our model assumes dividends resume for FY26. Our FY25 forecasts have been realigned to match revised guidance, with a slightly more cautious stance on growth for FY26. Management’s target for operating margins of 16–17% by FY27 remains in place, predicated on the targeted cost reductions in the mid-term management plan.


MFE-ProSieben: Spread Closed, Control Still in Play

By Jesus Rodriguez Aguilar

  • MFE secured 43.6% of ProSieben; board supports its offer. PPF stalled at 18.4% with expired bid. The arbitrage spread compressed, leaving minimal upside but structural consolidation remains pivotal.
  • Short-Term arbitrage returns are capped (+0.4% base case), while downside risk persists if blocking dynamics resurface. The medium-term value case depends on synergy delivery, with 18–35% EPS accretion possible.
  • Key milestones: September 1 end of extended acceptance, September 4 final results. Thereafter, MFE may pursue creeping acquisitions under Germany’s best-price rule, progressively consolidating control and enabling strategic integration.

Isn’t the Market Impatient for the Companies to Implement Management Reforms?

By Aki Matsumoto

  • More companies are mentioning share buybacks, reducing cross-shareholdings, capital allocation policies, and capital costs. However, the ROE of most companies has not improved significantly.
  • “TSE’s request” is at critical juncture addressing whether it’ll lead to formal improvements such as the introduction of corporate governance code, or whether it’ll enable sustainable growth in corporate value.
  • Looking at recent market trends, investors are increasingly expecting activist investors to directly demand management reforms from companies, in anticipation that it’ll take time to realize results of internal reforms.

Aramark: Initiation Of Coverage- How They Are Thriving In Sports & Education & Why Their Revenues Keep Climbing?

By Baptista Research

  • Aramark’s third quarter of fiscal 2025 showcased a blend of record-breaking revenues, strategic client wins, and persistent operational challenges.
  • The company reported record-setting revenues of $4.6 billion, a 6% increase, alongside a significant achievement in adjusted EPS growth of nearly 30%.
  • This performance was largely driven by organic growth, strategic client engagements, and elevated retention rates, exceeding 97% in both U.S. and International Food Services segments.

VNCE: Snapping the Store: Creating New Seasons; Reiterate Buy, $4 PT

By Small Cap Consumer Research

  • We are reiterating our Buy rating, $4 price target and projections for Vince Holding after visiting stores in Connecticut, Long Island and New Jersey.
  • Given the company’s response to tariffs has somewhat muddied the traditional product flows, our visits were a combination of two seasons (Pre-Fall 1 & 2) in a period where traditionally a third season (Pre-Fall 3) is debuting.
  • Did it matter?

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: First Pacific Co, Samsung Life Insurance, Hamilton Lane, Seazen Holdings , Picton Property Income and more

By | Daily Briefs, Financials

In today’s briefing:

  • First Pacific (142 HK) Is Fully Valued Here
  • True Aspect (Trade-Wise) Of the Samsung Life Accounting Issue: Today’s Biggest Market Narrative
  • Hamilton Lane: Initiation of Coverage- Reinventing Its Distribution Strategy — How Will Its Innovation Shape Private Market Leadership?
  • Lucror Analytics – Morning Views Asia
  • Picton Property Income — A 13.5% Q1 shareholder return


First Pacific (142 HK) Is Fully Valued Here

By David Blennerhassett


True Aspect (Trade-Wise) Of the Samsung Life Accounting Issue: Today’s Biggest Market Narrative

By Sanghyun Park

  • Both accounting issues are complex, but intense regulator scrutiny fuels the Samsung Life Act case, sparking governance reshuffle bets and driving today’s Samsung Life stock pop.
  • Accounting rechecks could spark divestment fears or governance-driven rerating, creating a classic headline-driven, bidirectional trading setup.
  • Near-Term, this is a headline-driven momentum setup: Samsung Life longs/shorts, ready to pivot, with relative-value plays vs financial peers or Samsung’s governance-linked names.

Hamilton Lane: Initiation of Coverage- Reinventing Its Distribution Strategy — How Will Its Innovation Shape Private Market Leadership?

By Baptista Research

  • Hamilton Lane’s first quarter of fiscal 2026 showcased a multifaceted financial performance, marked by both growth and areas of concern.
  • The company’s total asset footprint has seen a 5% year-on-year increase, reaching $986 billion, indicating robust growth across both specialized funds and customized separate accounts.
  • These asset categories contributed significantly to the near $11 billion increase in Assets Under Management (AUM), now totaling $141 billion, reflecting a substantial 9% growth year-over-year.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Seazen Group, Japfa Comfeed
  • UST yields declined 1-2 bps yesterday, amid limited macro catalysts and following good demand for an auction of 20Y notes. The yield on the 2Y UST was unchanged at 3.75%, while the yield on the 10Y UST fell 2 bps to 4.29%.
  • Equities retreated for a second day, driven by broad decreases in tech heavyweights amid concerns over AI profitability. The S&P 500 slid 0.2% to 6,396, while the Nasdaq was down 0.7% at 21,173.

Picton Property Income — A 13.5% Q1 shareholder return

By Edison Investment Research

Picton Property Income (PCTN) delivered a 1.9% NAV total return in Q126, a combination of dividends (116% covered by EPRA earnings) and modest NAV growth. Lease events continue to unlock reversionary rent potential and portfolio repositioning continues. Share repurchases have contributed to strong share price gains in the year to date, but the discount to NAV remains 25% and is, in our view, an attractive opportunity.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: TSMC (2330.TT; TSM.US): 2nm Production Schedule in US Could Be One Year Ahead of Previous Schedule. and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • TSMC (2330.TT; TSM.US): 2nm Production Schedule in US Could Be One Year Ahead of Previous Schedule.
  • Wuxi Biologics (2269 HK): Expanded Offering and Capacity Drive 1H25 Result; Accelerated Growth Ahead
  • iFAST Corporation Limited: Breaking Out
  • The Mosaic Company: Riding The Fertilizer Boom With Pricing Power & Market Edge!
  • A Defining Bet: Intel’s New Capital and the Case for Buying a Stake in Taiwan’s UMC
  • KS / Kuaishou (1024 HK): 2Q25, Op Profit Up by 35% YoY, 91% Upside
  • 2025 High Conviction – Freee: 4Q Setback Is Only Temporary
  • Masa’s AI Double Down: Masterstroke or Misstep?
  • CRM US – Salesforce Bets On Agentic Automation: What The Regrello Acquisition Could Unlock!
  • The Beat Ideas: Lumax Auto Technologies – Accelerating Ahead with the 20.20.20.20 Strategy


TSMC (2330.TT; TSM.US): 2nm Production Schedule in US Could Be One Year Ahead of Previous Schedule.

By Patrick Liao

  • TSMC Chairman C.C. Wei previously emphasized that customer demand for 2nm technology surpasses that for 3nm, and the company is actively working to expand production capacity. 
  • For 2nm technology, we expect production to take place at the Tainan fab, ahead of the U.S. Arizona fab and earlier than the previously anticipated 2028 timeline.
  • Taiwan Semiconductor (TSMC) – ADR (TSM US)’s next generation 2nm development is actively progressing.

Wuxi Biologics (2269 HK): Expanded Offering and Capacity Drive 1H25 Result; Accelerated Growth Ahead

By Tina Banerjee

  • Wuxi Biologics (2269 HK) logged solid performance in 1H25, with revenue growing 16% YoY to RMB10B and net profit increasing 55% YoY to RMB3B. Revenue from continuing operations grew 20%.
  • Total backlog reached $20B as of June 30, 2025, including $11B service backlog, while the total backlog within three years stood at $4B, enhancing near-term revenue visibility.
  • The company raised 2025 revenue growth target to 14–16% YoY from 12–15% YoY earlier. This indicates 2H25 revenue to be RMB11,524M, up 14% YoY and 16% HoH.

iFAST Corporation Limited: Breaking Out

By GEMS Research – Aletheia Capital

  • IFAST SP has risen 28% since our initiation and has seen net institutional outflows of S$50m in the first week of the month.
  • We see further upside of 12%, as the value in terms of P/AUM is not reflected in the price.
  • Recent private transactions such as the Chocolate Finance Series A+ deal round indicate that iFAST is cheap relative to its assets. There is a strong chance of a buy back in 2026.

The Mosaic Company: Riding The Fertilizer Boom With Pricing Power & Market Edge!

By Baptista Research

  • The Mosaic Company recently shared its financial results for the second quarter of 2025, showcasing a mixed performance largely characterized by operational challenges but an optimistic future outlook.
  • The company’s efforts to enhance operating efficiencies and asset reliability are starting to bear fruit, though certain operational interruptions have impacted short-term outcomes, particularly in the phosphates segment.
  • For the quarter, The Mosaic Company reported net income of $411 million, a significant turnaround from last year’s net loss of $162 million.

A Defining Bet: Intel’s New Capital and the Case for Buying a Stake in Taiwan’s UMC

By Vincent Fernando, CFA

  • A major Intel balance sheet boost, backed by SoftBank, the U.S. government, and leading institutions, would enhance the company’s capacity to make bold bets on regaining global chip manufacturing leadership.
  • UMC’s market valuation is less than the capex for just one advanced fab. Intel would likely make a gain on its investment since it would cause UMC shares to rally.
  • For less than the cost of a single advanced fab, a large company could acquire UMC and gain chipmaking expertise approaching TSMC’s level; boosting returns across an entire fab network.

KS / Kuaishou (1024 HK): 2Q25, Op Profit Up by 35% YoY, 91% Upside

By Ming Lu

  • The growth rate of GMV (Gross Merchandise Value) rose to 18% YoY in 2Q25 from 15% YoY in 1Q25.
  • The operating margin improved to 13% in 2Q25 from 11% in 2Q24 so that operating profit increased by 35% YoY in 2Q25.
  • We conclude an stock upside of 91% for the next twelve months. Buy.

2025 High Conviction – Freee: 4Q Setback Is Only Temporary

By Shifara Samsudeen, FCMA, CGMA

  • Freee KK (4478 JP)  reported 4Q and full-year FY06/2025 results last week which disappointed the market leading to a sell-off.
  • After reporting 3-consecutive quarters of Adj. OP, profitability dipped in 4Q due to higher advertising and D&A costs. However, freee expects to return to profits in the current fiscal year. 
  • Following 4Q results, premium over Money Forward has disappeared and Freee is currently trading at a huge discount to MF which seems unwarranted

Masa’s AI Double Down: Masterstroke or Misstep?

By Raghav Vashisht

  • SoftBank widens its AI bet with a $2B stake in Intel, suffers a 12% dip over two consecutive days.
  • Nvidia’s dominance has hyperscalers wary of lock-in. With Amazon and Microsoft building their chips, SoftBank’s move lands right as the market searches for alternatives.
  • Can Son replicate Intel’s historic design-fab alignment in AI, or would execution risk outweigh his ecosystem-diversification logic?

CRM US – Salesforce Bets On Agentic Automation: What The Regrello Acquisition Could Unlock!

By Baptista Research

  • Salesforce is charging deeper into the AI frontier.
  • On August 18, 2025, the CRM titan announced a definitive agreement to acquire Regrello, an AI-native startup that specializes in transforming fragmented business processes into orchestrated, automated workflows.
  • The deal, expected to close in Salesforce’s fiscal Q3 2026, underscores the company’s commitment to building out its “agentic enterprise” vision—where human workers and AI agents collaborate in real time.

The Beat Ideas: Lumax Auto Technologies – Accelerating Ahead with the 20.20.20.20 Strategy

By Sudarshan Bhandari

  • Lumax’s strong product portfolio, global partnerships, and 80% market share in key segments position it as a dominant player in India’s automotive component industry.
  • Lumax’s strategic acquisitions, including IAC India and GreenFuel Mobility, and the “NorthStar Strategy” aim to drive revenue growth, operating margins, and leadership in clean mobility solutions.
  • Lumax’s SHIFT project enable technological integration, enhancing product offerings and content per vehicle, positioning LATL for long-term growth in the automotive market.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: [IO Technicals 2025/34] Iron Ore Braces for Bullish Shift After Six-Day Slide and more

By | Daily Briefs, Macro

In today’s briefing:

  • [IO Technicals 2025/34] Iron Ore Braces for Bullish Shift After Six-Day Slide
  • How To Bet Against The Bubble… Without Going Bust
  • Asian Equity: As the Result Season Nears Its End, Asian EPS Estimates Suffer a Surprising Downgrade
  • Indonesia Economics: 2026 Budget Stretches Credibility
  • Walker’s Weekly: Dr. Jim’s Summary of Key Global Macro Developments – 22 August 2025
  • Deals, Recycling, Research And AI Power Thailand’s Rubber Shift
  • CX Daily: Coding Jobs No Longer Sure Thing for U.S.-Educated Chinese


[IO Technicals 2025/34] Iron Ore Braces for Bullish Shift After Six-Day Slide

By Umang Agrawal

  • Iron ore drops on Tangshan curbs, but stable hot metal output underpins near-term price support. 
  • Managed money participants remain net long in iron ore, but softer buying momentum signalled profit-taking.  
  • Mean reversion and bullish MA crossover signal upside potential for the 62%/65% spread. 

How To Bet Against The Bubble… Without Going Bust

By Finimize Research

  • Markets feel frothy right now – sentiment’s euphoric, valuations are near the ceiling – but trying to call the exact top is usually a losing game. 
  • It may be tempting to short the market, but the smarter move is to use efficient, asymmetric hedges: trades that don’t cost but pay out big when things crack.
  • Right now, these hedges’ prospects are unusually attractive: risks are stacked high, but insurance – volatility – is still relatively cheap

Asian Equity: As the Result Season Nears Its End, Asian EPS Estimates Suffer a Surprising Downgrade

By Manishi Raychaudhuri

  • As the earnings reporting season nears completion, our EPS estimate tracker reveals a downgrade to Asian EPS. AxJ EPS declined only 0.5%-0.8%. But several constituent markets’ EPS declined much more.
  • Asian EPS estimates were supported by China and somewhat surprisingly, Thailand. Indian estimates continued to decline. Even Korea and Taiwan, the recent earnings outperformers, were downgraded during this season. 
  • Unlike Asia, US EPS estimates rose during this season. Japan’s and Europe’s declined. In a subsequent note we shall track the estimates of all the sectors in each Asian Market.

Indonesia Economics: 2026 Budget Stretches Credibility

By Manu Bhaskaran

  • The first full-year budget of the Prabowo government envisions continued adherence to the country’s strict fiscal rules. 
  • The fiscal assumptions on growth, revenue, and expenditures, however, are far from conservative. This exerts risks to the fiscal consolidation path. 
  • A medium-term goal of balancing the budget by 2028 is unattainable given the government’s spending commitments and headwinds to the economy.

Walker’s Weekly: Dr. Jim’s Summary of Key Global Macro Developments – 22 August 2025

By Dr. Jim Walker

  • Asian economies remain resilient in H1 2025, though global weakness and tariffs could pressure exports in the second half.

  • Current market strength echoes 2007, masking underlying US and European economic softness with risks of a sharp reversal.

  • China’s headline data looks soft, but domestic demand, liquidity, and appliance sales suggest resilience despite persistent property sector weakness.


Deals, Recycling, Research And AI Power Thailand’s Rubber Shift

By Vinod Nedumudy

  • Bridgestone reshapes carbon black strategy with Tokai Carbon  
  • Hanwa invests in Thai tyre pyrolysis venture  
  • Sri Trang bets on AI and workforce upskilling

CX Daily: Coding Jobs No Longer Sure Thing for U.S.-Educated Chinese

By Caixin Global

  • Jobs /In Depth: Coding jobs no longer sure thing for U.S.-educated Chinese
  • Commodity/: Hong Kong joins LME’s global delivery system with eight certified warehouses
  • Delivery /: Couriers hike prices in face of toxic competition crackdown

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: KB Financial, Samsung Electronics, Goodai Global and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Korea’s Dividend Narrative Is Back: Unpacking the DP’s New Bill and Its Backstory
  • US Government May Acquire Equity Stakes in Samsung Electronics and TSMC
  • Goodai Global (Unlisted) – The Most Aggressive M&A Player in the Korean Cosmetics Industry


Korea’s Dividend Narrative Is Back: Unpacking the DP’s New Bill and Its Backstory

By Sanghyun Park

  • A new bill cutting Korea’s dividend tax hit the tape, giving local dividend plays an immediate boost on the news flow.
  • The presidential office is aligned on pushing the dividend tax below the 27.5% CGT floor. The new party leader is also tightly syncing with the Blue House to avoid clashes.
  • The DP’s tax cut move today puts the gov’s dividend narrative back in play with juice. We need setups to ride this theme.

US Government May Acquire Equity Stakes in Samsung Electronics and TSMC

By Douglas Kim

  • According to Reuters, the US government may be interested in acquiring equity stakes in Samsung Electronics and TSMC in exchange for CHIPS and Science Act grants.
  • The US government is exploring ways to take equity stakes in these two Asian tech giants that have been expanding their semiconductor facilities in the United States.
  • If the US government decides to invest $10 billion each in Samsung Electronics and TSMC, they would represent about 3% and 1% of Samsung Electronics and TSMC’s market caps, respectively. 

Goodai Global (Unlisted) – The Most Aggressive M&A Player in the Korean Cosmetics Industry

By Douglas Kim

  • Goodai Global is the most aggressive M&A player in the Korean cosmetics industry. It has grown its business mainly through M&As.
  • It has achieved the strongest growth in sales and profits among the major Korean cosmetics companies in the past four years. 
  • In early August 2025, Goodai Global secured 800 billion won, with a pledge to go public within three years. Goodai’s value is estimated to be about 4 trillion won. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Lynch Group Holdings, Abacus Storage King, Fortescue Metals and more

By | Australia, Daily Briefs

In today’s briefing:

  • Lynch Group (LGL AU): (Another) Clean Offer From TPG
  • Lynch Group (LGL AU): TPG’s Scheme Offer
  • Abacus Storage (ASK AU): Time To Get Some Exposure?
  • Abacus Storage King (ASK AU): Caution Is Warranted
  • Fortescue (FMG AU) Results on 26 Aug: Expected Price Swings and Volatility Outlook


Lynch Group (LGL AU): (Another) Clean Offer From TPG

By David Blennerhassett

  • Lynch Group (LGL AU), an integrated wholesale floral play, has entered into a Scheme Implementation Deed with  Hasfarm Holdings and Darwin Aus Bidco – both of which are TPG entities.
  • Hasfarm is offering A$2.245/share, a 28.3% premium to last close. The consideration includes a fully franked dividend of A$0.09/share. It’s April 2021 IPO price was A$3.60/share.
  • The Offer has unanimous board support. 38.5% of the register is supportive. Hasfarm has also entered into a call option for 19.9% of shares out. Done deal.

Lynch Group (LGL AU): TPG’s Scheme Offer

By Arun George

  • Lynch Group Holdings (LGL AU) has entered a scheme implementation deed with TPG Inc (TPG US) at A$2.245, a 28.3% premium to the undisturbed price of A$1.75 (19 August).
  • Lynch has several substantial shareholders, which poses a vote risk. Encouragingly, four out of eight substantial shareholders are supportive.
  • The offer is attractive compared to historical trading ranges. The scheme meeting is estimated to be in November, with payment in December. 

Abacus Storage (ASK AU): Time To Get Some Exposure?

By David Blennerhassett

  • On the 7th April, the Ki Corporation/Public Storage (PSA US) consortium announced a NBIO, by way of a Scheme, for shares not held in Abacus Storage (ASK AU) at A$1.47/security.
  • ASK rejected the Offer on the 13th May. The Kirsh-led consortium bumped non-binding terms 14.7% to A$1.65/share on the 14th July, and was granted six weeks of due diligence.
  • DD expires on or around the 1st September. Nathan Kirsh directly/indirectly holds a 59.47% stake in ASK. Currently trading at a 7.5% spread to the indicative terms. 

Abacus Storage King (ASK AU): Caution Is Warranted

By Arun George

  • The six-week due diligence for Ki Corporation and Public Storage (PSA US)‘s A$1.65 offer for Abacus Storage King (ASK AU) ends on 1 September.
  • Some readers have asked if ASK is attractive at the current 7.5% gross spread. I think caution is warranted as there is a medium-to-high probability of no deal.
  • The probability of a binding scheme is low, as NSR will block it, and the Board requires a bump to recommend it. A takeover offer is not a credible alternative. 

Fortescue (FMG AU) Results on 26 Aug: Expected Price Swings and Volatility Outlook

By Gaudenz Schneider

  • Timing:Fortescue (FMG AU) is scheduled to report its FY2025 full-year results on Tuesday, 26 August 2025.
  • Highlight: The options market provides estimates for the anticipated price move and the upcoming dividend. Implied volatility is projected to decline post-event; this Insight maps the resulting term structure.
  • Why Read: Get the expected move, the dividend outlook, and a clear view of the post-event volatility term structure to be ready for results day.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Pop Mart, Hansoh Pharmaceutical Group , Smart Share Global, Ascletis Pharma Inc, Wanguo International Mining, Yum China Holdings , Megatronix Inc., JNBY Design Ltd, Country Garden Holdings Co, Wuxi Biologics and more

By | China, Daily Briefs

In today’s briefing:

  • Hang Seng Indexes: Announcement Tomorrow; Potential Changes & Updated Flows
  • Hansoh Pharmaceutical (3692 HK): Placing Shares to Fund R&D Amid Stellar 1H Performance
  • Hillhouse’s Competing Bid Challenges Smart Share Global’s Management-Led Privatization
  • Ascletis Pharma (1672 HK): Placement Bleak; Commercialization To Take Time; Lack Formidable Pipeline
  • Wanguo Gold Group Placement – Industry Momentum Strong, Stock Run-Up Quite a Bit, but Deal Is Small
  • Yum China: Focus On Innovation & Customer Engagement to Foster Solid Growth Channels Via Advanced Digital Capabilities!
  • Megatronix Inc. Pre-IPO: Favorable Growth Drivers, But Losses and Concentration Risks Persist
  • HK-Listed Apparel & Footwear Screener Aug 2025: Lever Style (1346 HK) Conference Call
  • Lucror Analytics – Morning Views Asia
  • Wuxi Biologics (2269 HK) 25H1 – Concerns Behind the Performance Rebound


Hang Seng Indexes: Announcement Tomorrow; Potential Changes & Updated Flows

By Brian Freitas


Hansoh Pharmaceutical (3692 HK): Placing Shares to Fund R&D Amid Stellar 1H Performance

By Tina Banerjee

  • Hansoh Pharmaceutical Group (3692 HK) is placing 108M shares at the price of HK$36.30 per share. 65% of the proceeds will be used for the R&D of new innovative drugs.
  • Hansoh’s late-stage pipeline seems to be interesting, as its key focus areas being oncology and metabolic diseases, which are among the fast-growing therapeutic areas, with huge addressable patient population.
  • Hansoh has announced better-than-expected 1H25 result, with both revenue and net profit beating consensus. Innovative drugs revenue increased 22% YoY to RMB6B, contributing 82.7% of total revenue.

Hillhouse’s Competing Bid Challenges Smart Share Global’s Management-Led Privatization

By Special Situation Investments

  • Smart Share Global’s management consortium signed a definitive agreement to acquire the company at $1.25/ADS, later challenged by Hillhouse’s $1.77/ADS bid.
  • Hillhouse’s competing bid is 40% higher than management’s offer, with significant shareholder stakes potentially influencing the outcome.
  • EM’s business is unprofitable, with declining power bank rentals, but holds a net cash pile of $1.6/ADS.

Ascletis Pharma (1672 HK): Placement Bleak; Commercialization To Take Time; Lack Formidable Pipeline

By Tina Banerjee

  • Ascletis Pharma Inc (1672 HK) announced the placement of 52.4M shares for subscription at HK$16.45 per share.
  • The company intends to use 90% of proceeds for further R&D of its drug candidates with respect to both subcutaneously injected peptides and oral peptides, into clinical trials for obesity.
  • The company will take time to cash in fully from the commercialization efforts in near future, given the limited opportunity it has in terms of the drug pipeline basket.

Wanguo Gold Group Placement – Industry Momentum Strong, Stock Run-Up Quite a Bit, but Deal Is Small

By Akshat Shah

  • Wanguo International Mining (3939 HK) is looking to raise upto US$96m via a 2.1% stake sale, while Prominent Investment Holding is looking to pare down another 0.7%, to raise US$32m.
  • The company intends to use the proceeds towards funding the expansion of its Gold Ridge Mine in the Solomon Islands, along with other business development purposes.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Yum China: Focus On Innovation & Customer Engagement to Foster Solid Growth Channels Via Advanced Digital Capabilities!

By Baptista Research

  • Yum China Holdings, Inc. reported strong financial results for Q2 2025, marked by new record levels in revenue, operating profit, and operating margin.
  • The company’s dual-focused strategy emphasizing both same-store sales and system sales growth has yielded significant results.
  • Notably, overall same-store sales grew by 1%, driven by a 17% increase in same-store transactions at Pizza Hut and 5% system sales growth at KFC.

Megatronix Inc. Pre-IPO: Favorable Growth Drivers, But Losses and Concentration Risks Persist

By Hong Jie Seow

  • Megatronix Inc. (1888582D CH)  is looking to raise about US$100m in its upcoming Hong Kong IPO.
  • MI is an innovation-driven automotive technology company. MI focuses on developing and delivering AI-powered integrated domain control solutions that enable automakers to build the next generation of software-defined vehicles.
  • In this note, we look at the company’s past performance.

HK-Listed Apparel & Footwear Screener Aug 2025: Lever Style (1346 HK) Conference Call

By Sameer Taneja

  • Tariff confusion has hit stocks, but the names in focus continue to be resilient as they pass on the costs, and the future impact of demand is to be determined. 
  • The investing world is now searching for stocks that are not directly affected by Trump tariffs. Lever Style (1346 HK) is one such stock trading at 7.2x trailing PE.
  • With a trailing dividend yield of 6.2%, net cash of 27% of market cap, and impressive metrics on growth, this is a stock worth exploring. 

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Country Garden, Softbank Group, Xiaomi Corp, Sunny Optical
  • UST yields declined 2-3 bps across the curve yesterday, with limited catalysts on the macro front and amid a sell-off in equities. The yield on the 2Y UST fell 2 bps to 3.75%, while the yield on the 10Y UST declined 3 bps to 4.31%. Equities retreated, driven by a sell-off in tech stocks. The S&P 500 declined 0.6% to 6,411, while the Nasdaq slumped 1.5% to 21,315.
  • In the US, July housing starts rose 5.2% m-o-m (-1.8% e / 5.9% p) to an annualised 1.43 mn units. That said, the July (preliminary) building permits fell 2.8% m-o-m (-0.5% e / -0.1% p) to an annualised 1.35 mn units.

Wuxi Biologics (2269 HK) 25H1 – Concerns Behind the Performance Rebound

By Xinyao (Criss) Wang

  • WuXi Bio’s 25H1 growth was driven by XDC against the backdrop of BD wave of innovative drug assets. Coupled with biotech booming market, we witnessed obvious recovery in CXO’s performance. 
  • Intensive share reduction by major shareholders has weakened market confidence in long-term value. Given Li Ge’s rich experience in capital operation, WuXi Bio’s valuation potential may have been fully realized.
  • Current investment logic has shifted to the growth of overseas BD/licensing cooperation based on China’s low-priced but high-quality innovative drugs due to engineer dividend, which may have certain growth ceilings.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Astera Labs , Karman Holdings, Intel Corp, Jacobs Solutions , Broadridge Financial Solutions, Inc, Intl Flavors & Fragrances, Comtech Telecommunications, Kyivstar Group, Leidos Holdings and more

By | Daily Briefs, United States

In today’s briefing:

  • Astera Labs: Initiation of Coverage -Taurus & Aries Product Diversification As a Key Growth Strategy!
  • Karman Holdings Inc.(KRMN) Six Month Summary: A Model Debut That Opened the Door for Moonshots
  • Intel In The Hot Seat: U.S. Government Eyes Stake As Chipmaker Stumbles
  • Jacobs Solutions: An Advanced Facilities & Water Sector Momentum for Future Revenue Growth & Project Execution!
  • Broadridge Financial Solutions: These Are The 4 Biggest Challenges In Its Path In 2025 & Beyond!
  • IFF Expands Global Footprint as Emerging Markets Unlock New Revenue Streams!
  • CHIPS Act Money For Equity Stake, Pay For China Play? For Goodness Sake!
  • Comtech Telecommun (CMTL) – Wednesday, May 21, 2025
  • Kyivstar (KYIV US): Structural Long – From Ukraine’s Resilience to Renewal; Uklon Embedded Value
  • Leidos Holdings: Initiation of Coverage- Expaning Border Security Tech But Will $3 Billion in Funding Fuel Sufficient Growth?


Astera Labs: Initiation of Coverage -Taurus & Aries Product Diversification As a Key Growth Strategy!

By Baptista Research

  • Astera Labs, in its second quarter of fiscal year 2025, showcased robust financial performance and strategic advancement in its market positioning.
  • The company reported revenue of $191.9 million, reflecting a 20% increase from the previous quarter and a notable 150% year-over-year rise.
  • This substantial revenue growth was attributed to increased demand in both its signal conditioning and switch fabric product lines, notably with the Scorpio P-Series switches.

Karman Holdings Inc.(KRMN) Six Month Summary: A Model Debut That Opened the Door for Moonshots

By IPO Boutique

  • The specialist in missile defense and space systems, priced its upsized 23.0 million share offering at $22.00—$2.00 above the marketed range—and opened at $30.00 for a 36.3% gain.
  • The company completed a follow-on offering on July 24th, selling 21 million shares (upsized from 20 million) at $49.00.
  • With a successful follow-on behind it, better-than-expected results, and a robust cash position, Karman has set the benchmark for how to execute a space and defense IPO in 2025.

Intel In The Hot Seat: U.S. Government Eyes Stake As Chipmaker Stumbles

By Baptista Research

  • Intel is suddenly at the center of a high-stakes drama.
  • Just this month, the Trump administration reversed its public criticism of CEO Lip Bu Tan—who had been accused of being “conflicted” due to his past China ties—and moved into “constructive discussions” about a possible government equity stake in the company .
  • That shift followed a White House meeting that apparently reset the tone, with Trump calling Tan’s journey “amazing” after once demanding his resignation .

Jacobs Solutions: An Advanced Facilities & Water Sector Momentum for Future Revenue Growth & Project Execution!

By Baptista Research

  • Jacobs presented strong fiscal third-quarter 2025 results, with both adjusted EPS and revenue targets meeting or surpassing expectations.
  • The quarter was marked by a 25% increase in adjusted EPS to $1.62, buoyed by net revenue growth of 7% and substantial year-over-year margin expansion.
  • The company’s backlog grew 14% to a record $23 billion, and bookings maintained a positive trajectory, positioning Jacobs favorably for upcoming quarters.

Broadridge Financial Solutions: These Are The 4 Biggest Challenges In Its Path In 2025 & Beyond!

By Baptista Research

  • Broadridge Financial Solutions presented a robust financial performance in its fiscal fourth quarter and full year 2025 results, signaling positive momentum and strategic positioning for future growth.
  • The company reported a 7% increase in recurring revenue on a constant currency basis and an 11% growth in adjusted earnings per share (EPS), in line with its long-term objectives.
  • This financial achievement was complemented by the strategic execution in key areas such as democratization and digitization of governance, capital markets innovation, and modernization of wealth management.

IFF Expands Global Footprint as Emerging Markets Unlock New Revenue Streams!

By Baptista Research

  • The recent financial results for International Flavors & Fragrances Inc. (IFF) reveal a balanced but challenging landscape for the company, marked by both growth strides and headwinds across various business segments.
  • In the second quarter of 2025, IFF reported a revenue increase of over 3% year-over-year, reaching just above $2.75 billion.
  • Additionally, the adjusted operating EBITDA grew by approximately 6% to $552 million, with a margin improvement of 50 basis points.

CHIPS Act Money For Equity Stake, Pay For China Play? For Goodness Sake!

By William Keating

  • US commerce secretary Howard Lutnick confirmed that the US Administration is pursuing a strategy of converting CHIPS Act funding into equity stakes with Intel acting as its guinea pig
  • It seems clear that Mr. Lutnick is bent on applying the same formula with other beneficiaries of US CHIPs Act funding
  • CHIPs Act Dollars for Equity, Pay For China Play may seem like innovative ideas but in reality they are a slippery slope to confusion & chaos. Who or what’s next?

Comtech Telecommun (CMTL) – Wednesday, May 21, 2025

By Value Investors Club

Key points (machine generated)

  • Comtech plans to announce the sale of its Public Safety / NG911 business unit, which has significant revenue and EBITDA.
  • The business unit’s valuation could range from $400 million to $800 million, impacting Comtech’s financial standing and debt alleviation.
  • A higher sale price could provide up to $300 million in net cash, greatly enhancing Comtech’s equity value.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Kyivstar (KYIV US): Structural Long – From Ukraine’s Resilience to Renewal; Uklon Embedded Value

By Vincent Fernando, CFA

  • Ukraine’s leading digital operator with 24m mobile and 1.1m broadband users, providing critical national infrastructure and direct exposure to the country’s recovery and EU-aligned digital renewal.
  • Uklon as a transformative asset. With 100m+ annual rides and 100k drivers, Uklon adds unicorn potential and positions Kyivstar to anchor high-frequency platforms powering Ukraine’s next economic chapter.
  • Robust financial profile with re-rating upside: US$1.2bn 2025E revenue, US$647m EBITDA, zero debt; trading at 5.2x EV/EBITDA vs peer 6.5x, with upside from ARPU convergence and reconstruction.

Leidos Holdings: Initiation of Coverage- Expaning Border Security Tech But Will $3 Billion in Funding Fuel Sufficient Growth?

By Baptista Research

  • Leidos’ second quarter results for 2025 reflected both positive growth and notable challenges.
  • The company recorded robust revenue growth of 4.8% year-to-date, achieving record profitability with a 15.2% EBITDA margin and a 28% increase in operating cash flow for the quarter.
  • These achievements were realized amidst a dynamic market environment and were attributed to Leidos’ strategic focus, centered on five growth pillars under their North Star 2030 strategy: space and maritime, energy infrastructure, digital modernization and cyber, mission software, and managed health services.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Daiichi Sankyo, Kokusai Electric , Nikkei 225, ROHM Co Ltd, Nitto Boseki, TSE Tokyo Price Index TOPIX, IHI Corp, Morito Co Ltd, Kawasaki Heavy Industries and more

By | Daily Briefs, Japan

In today’s briefing:

  • Daiichi Sankyo Placement – US$1.2bn Deal but Momentum Isn’t the Best, Last Deal Didn’t Do Well
  • Kokusai Electric (6525 JP): Q1 Miss; FY Guidance Maintained, 2H Ramp Critical, Valuation Discount
  • Nikkei 225 Index Outlook: Key Buy Targets To Watch
  • Rohm Co Ltd(6963 JP): Advancing from Breakdown to Breakthrough; Strong Outlook for Q2
  • Nittobo (3110 JP) – Q1 Solid, Guidance Retained; 2H Execution Key for AI-Led Growth
  • The Main Battlefield for Dissolution of Parent-Subsidiary Listings Will Shift to Standard Market
  • IHI Corporation (7013 JP) – Strong Orders, Weak Profits; Guidance Backloaded on Aero & Disposals
  • Morito (9837 JP) – An Over-A-Century-Old Company with a Strong, High-Margin Profit Structure…
  • Kawasaki Heavy (7012 JP) – Soft Start to FY26, Steep H2 Profit Ask Vs Guidance


Daiichi Sankyo Placement – US$1.2bn Deal but Momentum Isn’t the Best, Last Deal Didn’t Do Well

By Sumeet Singh

  • A group of shareholders are looking to raise up to US$1.2bn via selling most of their stake in Daiichi Sankyo (4568 JP) .
  • While the deal shouldn’t come as a surprise, given the ongoing cross-shareholding unwind,  the last deal in the stock didn’t do well.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Kokusai Electric (6525 JP): Q1 Miss; FY Guidance Maintained, 2H Ramp Critical, Valuation Discount

By Rahul Jain

  • Results: Q1 revenue ¥51.8B (–21% YoY) and OP ¥10.9B (–44%) came in weak, with DRAM softness offset partly by NAND strength.
  • Guidance: FY26/3 outlook (¥244B revenue, ¥55.2B OP) reiterated, implying a sharp 2H acceleration in shipments and margin recovery.
  • Valuation: Shares trade at ~11× EV/EBITDA, a discount to peers, but execution risk keeps the multiple constrained.

Nikkei 225 Index Outlook: Key Buy Targets To Watch

By Nico Rosti

  • As predicted in our July 15th insight, the Nikkei 225 (NKY INDEX) rallied past 41k (reached near 44k) and now, as predicted by our latest WEEKLY HEAT MAP, went down.
  • The index reached a low of 42724 this week, it is only mildly oversold so far, probability of reversal is around 52% at the moment.
  • Key support levels to watch are 42577 (Q2) and 41606 (Q3). A file with all our PRICE/TIME model dataset for the Nikkei 225 is attached at the end, for your reference. 

Rohm Co Ltd(6963 JP): Advancing from Breakdown to Breakthrough; Strong Outlook for Q2

By Sreemant Dudhoria,CFA

  • Advancing from Breakdown to Breakthrough:ROHM Co Ltd (6963 JP) returned to profitability in Q1FY25 on improved demand and cost controls with strong outlook for Q2.
  • Rohm is actively implementing structural reforms, with a priority on ensuring profitability in any market environment.  It is also drafting its second Medium-Term Management Plan for FY26 to FY28.
  • It continues to be available at significantly cheaper valuation versus peers of just 0.8x price to book. Also, it has been added to the Nikkei 225 Index recently.

Nittobo (3110 JP) – Q1 Solid, Guidance Retained; 2H Execution Key for AI-Led Growth

By Rahul Jain

  • Results: Q1 FY26 came in solid, with strength in Electronic Materials offsetting weakness in Insulation.
  • Guidance/Estimates: FY26 guidance was reiterated, and we retain our estimates, with 2H execution key.
  • Valuation: At ~9.5x EV/EBITDA FY26E, Nittobo looks inexpensive, with its monopoly T-glass exposure offering direct leverage to NVIDIA-driven AI/data center demand.

The Main Battlefield for Dissolution of Parent-Subsidiary Listings Will Shift to Standard Market

By Aki Matsumoto

  • Standard Market is home to companies that face challenges that fail to meet tradable shares ratio, can’t grow market capitalization, or feel it burdensome to meet governance and disclosure requirements.
  • TSE is likely to request companies listed on the Standard Market to disclose improvement measures in response to TSE’s requests, rather than raising the listing maintenance criteria.
  • 262 Standard Market companies are listed subsidiaries. It’s considered that the quickest way to improve the quality of the Standard Market is to delist these companies by eliminating parent-subsidiary listings.

IHI Corporation (7013 JP) – Strong Orders, Weak Profits; Guidance Backloaded on Aero & Disposals

By Rahul Jain

  • Q1 FY2026 results showed weak earnings (net profit –38% YoY) but a strong +29% YoY orderbook driven by Aero & Carbon Solutions.
  • Management retained FY2026 guidance, banking on aero aftermarket growth and disposal gains to drive a backloaded recovery.
  • Valuations (~14× EV/EBITDA, 24× P/E) look reasonable versus peers, but execution risks remain if disposals or aero demand underdeliver.

Morito (9837 JP) – An Over-A-Century-Old Company with a Strong, High-Margin Profit Structure…

By Sessa Investment Research

  • MORITO (hereafter, the Company) posted consolidated net sales of JPY 25,805 mn (+8.7% YoY), operating profit of JPY 1,570 mn (+5.9% YoY), ordinary profit of JPY 1,713 mn (+9.4% YoY), Profit attributable to owners of parent (hereafter, net profit) of JPY 2,359 mn (+69.3% YoY), which showed both an increase in revenue and profit.
  • The Company achieved record high H1 net sales, operating profit, and ordinary profit. The main drivers underpinning the strong earnings are the inclusion of Ms.ID in the scope of consolidation, higher revenue from existing businesses, and improvement in gross profit margin.
  • For FY2025/11, the Company forecasts net sales of JPY 56,000 mn (+15.4% YoY), operating profit of JPY 3,200 mn (+11.5% YoY), ordinary profit of JPY 3,300 mn (+9.9% YoY), and net profit of JPY 2,800 mn (+8.9% YoY). 


Kawasaki Heavy (7012 JP) – Soft Start to FY26, Steep H2 Profit Ask Vs Guidance

By Rahul Jain

  • Q1 revenue +10% YoY, with business profit up ~21% YoY on strength in Rolling Stock and ES&M, but headline net profit –72% YoY on FX headwinds and higher NCI drag.
  • Guidance / Revisions: FY26/3 guidance left unchanged, but steep H2 ask implies ~12% revenue and ~29% profit growth vs last year.
  • Outlook & Valuation: Near-term pressured by FX/tariffs, but aero/energy support medium-term growth; trades at ~14x NTM P/E, ~7.6x EV/EBITDA, a discount to peers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars